This episode of the Crux of Medtech features Sabine Bois, the former CEO of Occlutech.

Sabine is a medtech leader whose career spans founding startups, steering a company through bankruptcy, driving IPO prep, and ultimately leading as CEO.

Her story is raw, unfiltered, and filled with lessons about resilience, leadership, and navigating the brutal realities of medtech.

Key Topics:

• Sabine’s leap from small-town Germany to founding her first medtech startup

• Navigating bankruptcy and rebuilding into a successful acquisition

• The commercial lessons that reshaped her career trajectory

• Transition from CFO to CEO at Occlutech during global litigation and IPO prep

• The turbulence behind IPO readiness, audits, and roadshows

• Why passion and relentlessness matter more than resources
  

Related Insights:

• Failure wasn’t an option for the Wright brothers or for startups

• The CEO’s ability to adapt their pitch can make or break funding

• Timing and market cycles are often as critical as technology

• Strategics are approachable but require careful balance in what you share
  

Core Challenges:

• Surviving insolvency while protecting IP and technology

• Learning that a CEO’s first responsibility is revenue, not admin

• Facing last-minute IPO derailments and high-stakes investor negotiations

• Adjusting from European regulatory norms to the strict demands of the FDA

• Raising funds in today’s tougher, profitability-driven investor landscape

Tune in now to hear Sabine’s unfiltered journey through medtech’s toughest challenges and what it really takes to lead with resilience.